« Back
Home /
Peptide YY (Dog, Mouse, Porcine, Rat, 3-36)

Peptide YY (Dog, Mouse, Porcine, Rat, 3-36)

Item no.	BNTH-PYY-3726-PI-1mg
Manufacturer	BIOSYNTH
CASRN	126339-09-1
Amount	1 mg
Quantity options	1 mg 5 mg
Category	Neuroscience Metabolism Regulation of Appetite Molecular Targets for Neuroscience Obesity Reagents & Chemicals Molecules
Type	Molecules
Specific against	other
Citations	R.L.Batterham et al., N. Engl. J. Med., 349, 941 (2003). I.G.Halatchev and R.D.Cone, Cell Metab., 1, 159 (2005) PK Chelikani, et al, Am. J Phyiol Regul Integr Comp Physiol,, 293, R39, (2007). G.H.Ballantyne, Obes. Surg., 16, 651 (2006). C.Acuna-Goycolea and A.N.van den Pol, J. Neurosci., 25, 10510 (2005). Y.Shechter et al., FEBS Lett., 579, 2439 (2005). R.L.Batterham et al., Nature, 418, 650 (2002). D.Grandt et al., Regul. Peptides, 40, 161 (1992).
Smiles	CC(C)CC(C(=O)NC(CO)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(C)C(=O)NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC3=CNC=N3)C(=O)NC(CC4=CC=C(C=C4)O)C(=O)NC(CC(C)C)C(=O)NC(CC(=O)N)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(C(C)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC5=CC=C(C=C5)O)C(=O)N)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C6CCCN6C(=O)C(CO)NC(=O)C(C)NC(=O)C(CC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C7CCCN7C(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C8CCCN8C(=O)C(CCCCN)NC(=O)C(C)N
ECLASS 10.1	32169090
ECLASS 11.0	32169090
UNSPSC	12000000
Alias	H-Ala-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Ser-Arg-Ty r-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln-Arg-Tyr-NH2; H-AKPEAPGEDASPEELSRYYASLRHYLNLVTRQRY-NH2
Available
Manufacturer - Category	Life Sciences / Peptides and Biochemicals / Research Peptides
Shipping Temperature	No Dry Ice
Storage Conditions	-20C
Molecular Weight	3, 980.45 g/mol
Model	Peptide YY (Dog, Mouse, Porcine, Rat, 3-36)
Description	PYY (3-36), a Y2 receptor agonist, is released from the body's gastrointestinal tract in proportion to caloric intake. It has been shown that peripheral injection of PYY (3-36) in rats inhibited food intake and reduced weight gain. In addition, infusion of PYY (3-36) in humans significantly decreased appetite and reduced food intake by 33% over 24h, which suggests that PYY (3-36) has a role in 'longer term' regulation of food intake. Thus, the PYY (3-36) may represent a lead compound for the development of drugs for the treatment of obesity.
Form	Acetate salt
One letter code	H-AKPEAPGEDASPEELSRYYASLRHYLNLVTRQRY-NH2

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 1 mg

available

Delivery expected until 6/12/2025

Express Delivery: Save 13 days

Compare

Add to wishlist

Recommend by mail